Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC
Clinical trial NCT05155124 · UNKNOWN
Trial details
- NCT number
- NCT05155124
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2022-10-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.